Personalized therapy for lung cancer: striking a moving target

af Pakkala, Suchita, Ramalingam, Suresh S.
Udgivet i JCI Insight (2018)

Necitumumab: a new therapeutic option for squamous cell lung cancer?

af Pillai, Rathi N., Ramalingam, Suresh S.
Udgivet i Transl Lung Cancer Res (2014)

Inhibition of insulin-like growth factor receptor: end of a targeted therapy?

af Pillai, Rathi N., Ramalingam, Suresh S.
Udgivet i Transl Lung Cancer Res (2013)

Second-Generation ALK Inhibitors: Filling the Non “MET” Gap

af Ramalingam, Suresh S., Khuri, Fadlo R.
Udgivet i Cancer Discov (2014)

Targeting EGFR in lung cancer: Lessons learned and future perspectives

af Steuer, Conor E., Ramalingam, Suresh S.
Udgivet i Mol Aspects Med (2015)

Immunotherapy in previously treated non-small cell lung cancer (NSCLC)

af Leal, Ticiana A., Ramalingam, Suresh S.
Udgivet i J Thorac Dis (2018)

Improving outcomes for brain metastases in EGFR mutated NSCLC

af Carlisle, Jennifer W., Ramalingam, Suresh S.
Udgivet i Transl Lung Cancer Res (2019)

Reply to N. Hanna et al and L. Xie et al

af Ramalingam, Suresh S., Dahlberg, Suzanne E.
Udgivet i J Clin Oncol (2020)

EGFR tyrosine kinase inhibitors (TKIs) for adjuvant therapy of early-stage non-small cell lung cancer (NSCLC): ready for the clinic?

af Steuer, Conor E., Ramalingam, Suresh S.
Udgivet i Transl Lung Cancer Res (2020)

Genetic Testing and Tissue Banking for Personalized Oncology: Analytical and Institutional Factors

af Miles, George, Rae, James, Ramalingam, Suresh S., Pfeifer, John
Udgivet i Semin Oncol (2015)

Gene Expression Profiling of Non-Small Cell Lung Cancer

af Singhal, Sunil, Miller, Daniel, Ramalingam, Suresh, Sun, Shi-Yong
Udgivet 2008

Targeting KRAS-Mutant Non–Small-Cell Lung Cancer: One Mutation at a Time, With a Focus on KRAS G12C Mutations

af Burns, Timothy F., Borghaei, Hossein, Ramalingam, Suresh S., Mok, Tony S., Peters, Solange
Udgivet i J Clin Oncol (2020)

Retinoic acid enhances TRAIL induced apoptosis in cancer cells by upregulating TRAIL receptor 1 expression

af Dhandapani, Latha, Yue, Ping, Ramalingam, Suresh S., Khuri, Fadlo R., Sun, Shi-Yong
Udgivet 2011

What is the role of maintenance therapy in the treatment of non-small cell lung cancer?

af Jiang, Yixing, Owonikoko, Taofeek K., Ramalingam, Suresh S., Khuri, Fadlo R., Belani, Chandra P.
Udgivet 2010

Phosphorylated Eukaryotic Translation Initiation Factor 4 (eIF4E) is Elevated in Human Cancer Tissues

af Fan, Songqing, Ramalingam, Suresh S., Kauh, John, Xu, Zhiheng, Khuri, Fadlo R., Sun, Shi-Yong
Udgivet 2009

Guidance on the Clinical Management of Electronic Cigarette or Vaping-Associated Lung Injury

af Rice, Shawn J., Hyland, Victoria, Behera, Madhusmita, Ramalingam, Suresh S., Bunn, Paul, Belani, Chandra P.
Udgivet i J Thorac Oncol (2020)

Diallyl Trisulfide Selectively Causes Bax and Bak Mediated Apoptosis in Human Lung Cancer Cells

af Xiao, Dong, Zeng, Yan, Hahm, Eun-Ryeong, Kim, Young-Ae, Ramalingam, Suresh, Singh, Shivendra V.
Udgivet 2009

Vorinostat increases carboplatin and paclitaxel activity in non-small cell lung cancer cells

af Owonikoko, Taofeek K., Ramalingam, Suresh S., Kanterewicz, Beatriz, Balius, Trent, Belani, Chandra P., Hershberger, Pamela A.
Udgivet 2010

Clinical Practice Guidelines for Cancer Care: Utilization and Expectations of the Practicing Oncologist

af Dillmon, Melissa, Goldberg, John M., Ramalingam, Suresh S., Mayer, Robert J., Loehrer, Patrick, Van Poznak, Catherine
Udgivet 2012

Cisplatin Induces a Mitochondrial-ROS Response That Contributes to Cytotoxicity Depending on Mitochondrial Redox Status and Bioenergetic Functions

af Marullo, Rossella, Werner, Erica, Degtyareva, Natalya, Moore, Bryn, Altavilla, Giuseppe, Ramalingam, Suresh S., Doetsch, Paul W.
Udgivet 2013